Wealthspire Advisors (Maryland)’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Wealthspire Advisors (Maryland)’s Portfolio SCMP Stock Details SCMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-9	Closed	–	–	2745
2017 Q4	$0	Hold	9	–	–	﹤0.01%	2638
2017 Q3	$0	Buy	+9	New	+$101	﹤0.01%	2606

Other funds holding SCMP

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Wealthspire Advisors (Maryland)'s SCMP Position: Q1 2018 in Review

Wealthspire Advisors (Maryland) sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 9 shares.

Wealthspire Advisors (Maryland) first reported a position in SCMP in Q3 2017 and held it in 2 quarters. The position peaked at $0 in Q4 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

Wealthspire Advisors (Maryland) reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
Wealthspire Advisors (Maryland) sold 9 Sucampo Pharmaceuticals, Inc. shares in Q1 2018.
Wealthspire Advisors (Maryland) first reported a position in Sucampo Pharmaceuticals, Inc. in Q3 2017 and held it in 2 quarters.
Wealthspire Advisors (Maryland)'s Sucampo Pharmaceuticals, Inc. position peaked at $0 in Q4 2017.
3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on Wealthspire Advisors (Maryland)'s 13F filing for Q1 2018, filed 3 May 2018.